Gordon J. Freeman

5 ta ish

Harvard University

1. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

   Peng Jiang, Shengqing Gu, Deng Pan +12

   Maqola20183 iqtibos

   ABIABI:AkademIndex/2026.other.421748

2. In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

   Sean P. Arlauckas, Christopher Garris, Rainer H. Köhler +9

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.097041

3. Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects

   Yufei Wang, Alicia Buck, Brandon Piel +26

   Maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.340916

4. Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

   Spencer C. Liang, Yvette Latchman, Janet E. Buhlmann +4

   Maqola20032 iqtibos

   ABIABI:AkademIndex/2026.other.748207

5. PD-1 and Its Ligands in Tolerance and Immunity

   Mary Keir, Manish J. Butte, Gordon J. Freeman +1

   Sharh maqola20082 iqtibos

   ABIABI:AkademIndex/2026.other.748209